<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cunningham, Muriel</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Tesfaye, Solomon</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Treatments for Diabetic Neuropathy</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">33-33</style></pages><abstract><style  face="normal" font="default" size="100%">Diabetic painful neuropathy (DPN) causes painful symptoms in 30% of diabetes patients and has an association with cardiovascular disease mortality. Risk factors for DPN include hypertension, smoking, elevated triglycerides, elevated cholesterol, a high body mass index, a high HbA1C, and the duration of diabetes [Tesfaye et al. N Engl J Med 2005]. This article provides an overview of new pharmacological treatments and relevant clinical trials.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">6</style></volume></record></records></xml>